Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)

NCT01244035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treatment C
DRUG: Treatment D
DRUG: Treatment E
DRUG: Treatment F

Sponsor

Merck Sharp & Dohme LLC